medigraphic.com

2016, Number 1

<< Back Next >>

Revista Cubana de Angiología y Cirugía Vascular 2016; 17 (1)

Mortality and years of potential life lost from atherothrombotic disease in Cerro municipality

Puentes MIC, Aldama FA, Barnés DJA, Rodríguez ÁM

Language: Spanish
References: 27
Page: 25-35
PDF size: 186.92 Kb.


ABSTRACT

Introduction: Mortality data are the pillars of a wide range of indicators of varying complexity; they do not only represent tools for evaluation of the risk of dying in a population and the impact of diseases on health but also the severity of diseases and the survival rate of that population.
Objective: To estimate mortality and the years of potential life lost from atherothrombotic diseases in Cerro municipality.
Methods: Retrospective, descriptive and observational study was conducted on deaths occurred in Cerro municipality due to atherothrombotic diseases in the period of 2000 through 2006 and were analyzed by age, sex, location and causes. For the statistical analysis, the gross and typed mortality rates and the years of potential life lost rates were also estimated.
Results: downward trend in mortality and upward trend in the years of potential life lost were observed in this period. The mortality rate and the premature mortality were higher in women aged 65 and over. The percentage of deaths from peripheral atherothrombotic disease in a hospital center was higher.
Conclusions: Cerro municipality showed a downward trend in mortality from atherothrombotic disease but an upward trend in the years of potential life lost due to this cause, being the older women the most affected.


REFERENCES

  1. Astraín M. Indicador mortalidad. Análisis de la situación de Salud. La Habana: Editorial de Ciencias Médicas; 2004:26-46.

  2. Adrazo Gutiérrez Y. La mortalidad como expresión de las diferencias en las condiciones de vida Cuba 2000-2002 [tesis]. La Habana: Ministerio de Salud Pública, Escuela Nacional de Salud Pública “Carlos J. Finlay; 2004.

  3. Ergonzoli G. ¿La razón de mortalidad proporcional, cuán válida es? Rev Colombia Médica. 1999;30:132-7.

  4. Araya MR, Padilla SG. Trends in mortality from ischemic heart disease and acute myocardial infarction in Costa Rica.1970-2001]. Rev Panam Salud Pública. 2004;16(5):295-301.

  5. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128.

  6. Yaghoubi A, Safaie N, Azarfarin R, Alizadehasl A, Golzari SE. Evaluation of cardiovascular diseases and their risk factors in hospitalized patients in East azerbaijan province, northwest iran: a review of 18323 cases. J Tehran Heart Cent. 2013;8(2):101-5.

  7. Cheng Cheng L, Tan L, Zhang L, Wei S, Liu L, Long L, Zhang J. Chronic disease mortality in rural and urban residents in Hubei Province, China, 2008-2010. BMC Public Health. 2013;13:713.

  8. Centers for Disease Control and Prevention (CDC). Vital signs: avoidable deaths from heart disease, stroke, and hypertensive disease-United States, 2001-2010. MMWR Morb Mortal Wkly Rep. 2013;62(35):721-7.

  9. MINSAP. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2014. La Habana: Minsap; 2015 [citado 6 Jul 2015]. Disponible en: http://files.sld.cu/bvscuba/files/2015/04/anuario-estadistico-de-salud-2014.pdf

  10. Rodríguez Lucci F, Pujol Lereis V, Ameriso S, Povedano G, Díaz MF, Hlavnicka A. In-hospital mortality due to stroke. Medicina (Buenos Aires). 2013;73(4):331-4.

  11. Tsai J, Abe K, Boulet SL, Beckman MG, Hooper WC, Grant AM. Predictive accuracy of 29-comorbidity index for in-hospital deaths in US adult hospitalizations with a diagnosis of venous thromboembolism. PLoS One. 2013 Jul 26;8(7):e70061.

  12. Sánchez H, Albala C, Lera L. Años de vida perdidos por muerte prematura (AVPP) en adultos del Gran Santiago ¡Hemos ganado con Equidad. Rev Med Chile. 2005;133:575-82.

  13. Jordy Santana S. Mortalidad Evitable en el estado de Tocantins, Brasil 1996 a 2000 [tesis]. La Habana: Ministerio de Salud Pública, Escuela Nacional de Salud Pública “Carlos J. Finlay; 2002.

  14. Plass D, Chau PY, Thach TQ, Jahn HJ, Lai PC, Wong CM. Quantifying the burden of disease due to premature mortality in Hong Kong using standard expected years of life lost. BMC Public Health. 2013;13:863-7.

  15. Seuc AH, Domínguez E. Evolución de la carga de enfermedad debido a la mortalidad en Cuba: de 1990 a 2005. Cuad Saúde Pública. 2010;26(3). Doi: http://dx.doi.org/10.1590/S0102-311X2010000300018

  16. Seuc Jo AH, Domínguez Alonso E. Introducción a la estimación de la carga de los factores de riesgo en Cuba. Rev Cubana Salud Pública. 2009 [citado 30 Jun 2015];35(2). Disponible en: http://www.sld.cu/sitios/revsalud/index.php

  17. Zacca Peña E, Gran Álvarez MA, Martínez Morales MA, Fernández Viera MR. Calidad de las estadísticas de mortalidad en Cuba según cuantificación de causas de muerte imprecisas. Rev Cubana Salud Pública. 2010 [citado 30 Jun 2015];36(2):102-8. Disponible en: http://www.sld.cu/sitios/revsalud/index.php

  18. Uchendu OJ, Forae GD. Disease mortality patterns in elderly patients: A Nigerian teaching hospital experience in Irrua, Nigeria. Niger Med J. 2013 Jul;54(4):250-3.

  19. González González A, Campillo Motilva R. Morbi-mortalidad por enfermedad cerebrovascular de tipo isquémica. Rev Cubana Med Gen Integr. 2007 [citado 30 Jun 2015];23(4). Disponible en: http://scielo.sld.cu/pdf/mgi/v23n4/mgi03407.pdf

  20. Puras Mallagray E. Nuevas expectativas en el manejo de la aterotrombosis de los miembros inferiores. Ann Cir Card Vasc. 2003;9(2):103-7.

  21. Seuc AH, Domínguez Alonso E, Torres Vidal RM, Varona Pérez P. Algunas precisiones acerca de la mortalidad por enfermedades cardiovasculares en Cuba. Rev Cubana Salud Pública. 2011 [citado 30 Jun 2015];37(1). Disponible en: http://scielo.sld.cu/pdf/rcsp/v37n1/spu04111.pdf

  22. Chen Q, Smith CY, Bailey KR, Wennberg PW, Kullo IJ. Disease location is associated with survival in patients with peripheral arterial disease. J Am Heart Assoc. 2013;2(5):e000304.

  23. Gallardo Pérez UJ, Seuc Jo AH, Chirino Carreño N, Puentes Madera I, Rubio Medina Y. Mortalidad por enfermedades vasculares periféricas en Cuba en el año 2005. Rev Cubana Invest Bioméd. 2008 [citado 30 Jun 2015;27(2). Disponible en: http://scielo.sld.cu/pdf/ibi/v27n2/ibi10208.pdf

  24. Ruiz-Ramos M, Hermosín Bono T, Gamboa Antiñolo F. Trends in mortality due to cardiovascular diseases in Andalusia, Spain (1975-2004). Rev Esp Salud Pública. 2008;82(4):395-403.

  25. Ricard Génova-Maleras R, Catalá-López F, Fernández de Larrea-Baz N, Álvarez- Martín E, Morant-Ginestar C. The burden of premature mortality in Spain using standard expected years of life lost:a population-based study. BMC Public Health. 2011;11:787-90.

  26. Mani Mani Maniecka-Bryla I, Pikala M, Bryla M. Life years lost due to cardiovascular diseases. Kardiol Pol. 2013;71(10):1065-72.

  27. Domínguez Alonso E. Edad de ocurrencia de los fallecimientos por diabetes en Cuba. Rev Cubana Endocrinol. 2013 [citado 30 Jun 2015];24(1):3-7. Disponible en: http://scielo.sld.cu/pdf/end/v24n1/end02113.pdf




2020     |     www.medigraphic.com